Noxopharm Ltd has released a press release.
Noxopharm Dec 2020 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Noxopharm
- NOXCOVID Study Advances
- Pre-Clinical Breakthrough Discovery Set to Expand Pipeline
- Noxopharm Completes A$23m Placement to Fund Clinical Studies
- Independent Discovery Validates DARRT Cancer Therapy
- Veyonda To Be Tested In Combination With Opdivo In Trial
Later from Noxopharm
- Major Survival Benefit in Prostate Cancer Patients Announced
- LuPIN Survival Outcome Confirmed by Conference Presentation
- Appendix 4D and Half Year Financial Report
- Company Announcement Regarding Appendix 3Y Disclosures
- Noxopharm Receives A$4.59M Federal Gov R&D Tax Rebate
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm